JP2020019746A - Viscous antibacterial agent - Google Patents
Viscous antibacterial agent Download PDFInfo
- Publication number
- JP2020019746A JP2020019746A JP2018146611A JP2018146611A JP2020019746A JP 2020019746 A JP2020019746 A JP 2020019746A JP 2018146611 A JP2018146611 A JP 2018146611A JP 2018146611 A JP2018146611 A JP 2018146611A JP 2020019746 A JP2020019746 A JP 2020019746A
- Authority
- JP
- Japan
- Prior art keywords
- silver
- antibacterial agent
- ethanol
- viscous
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003242 anti bacterial agent Substances 0.000 title claims abstract description 58
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 64
- 229910052709 silver Inorganic materials 0.000 claims abstract description 57
- 239000004332 silver Substances 0.000 claims abstract description 57
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 55
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 230000008719 thickening Effects 0.000 claims abstract description 27
- -1 acrylic acid compound Chemical class 0.000 claims description 23
- 239000001506 calcium phosphate Substances 0.000 claims description 13
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 13
- 235000011010 calcium phosphates Nutrition 0.000 claims description 13
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 13
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 20
- 206010040880 Skin irritation Diseases 0.000 abstract description 2
- 230000036556 skin irritation Effects 0.000 abstract description 2
- 231100000475 skin irritation Toxicity 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000008213 purified water Substances 0.000 description 15
- 239000003002 pH adjusting agent Substances 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 230000000694 effects Effects 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 7
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 7
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 7
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 230000002688 persistence Effects 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 229960000686 benzalkonium chloride Drugs 0.000 description 4
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 4
- 238000002845 discoloration Methods 0.000 description 4
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 229910001923 silver oxide Inorganic materials 0.000 description 2
- RHUVFRWZKMEWNS-UHFFFAOYSA-M silver thiocyanate Chemical compound [Ag+].[S-]C#N RHUVFRWZKMEWNS-UHFFFAOYSA-M 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- KWVVTSALYXIJSS-UHFFFAOYSA-L silver(ii) fluoride Chemical compound [F-].[F-].[Ag+2] KWVVTSALYXIJSS-UHFFFAOYSA-L 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 2
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- VRPYMUDUDVQUPP-WCCKRBBISA-N (2S)-2-amino-4-methylsulfanylbutanoic acid silver Chemical compound N[C@@H](CCSC)C(=O)O.[Ag] VRPYMUDUDVQUPP-WCCKRBBISA-N 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- IVORCBKUUYGUOL-UHFFFAOYSA-N 1-ethynyl-2,4-dimethoxybenzene Chemical compound COC1=CC=C(C#C)C(OC)=C1 IVORCBKUUYGUOL-UHFFFAOYSA-N 0.000 description 1
- IWDUDCDZGOLTTJ-UHFFFAOYSA-N 1h-imidazole;silver Chemical compound [Ag].C1=CNC=N1 IWDUDCDZGOLTTJ-UHFFFAOYSA-N 0.000 description 1
- LRMSQVBRUNSOJL-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)F LRMSQVBRUNSOJL-UHFFFAOYSA-N 0.000 description 1
- YPJUNDFVDDCYIH-UHFFFAOYSA-M 2,2,3,3,4,4,4-heptafluorobutanoate Chemical compound [O-]C(=O)C(F)(F)C(F)(F)C(F)(F)F YPJUNDFVDDCYIH-UHFFFAOYSA-M 0.000 description 1
- ZXJBWUAALADCRI-UHFFFAOYSA-N 2-(octadecoxymethyl)oxirane Chemical compound CCCCCCCCCCCCCCCCCCOCC1CO1 ZXJBWUAALADCRI-UHFFFAOYSA-N 0.000 description 1
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- RBWNDBNSJFCLBZ-UHFFFAOYSA-N 7-methyl-5,6,7,8-tetrahydro-3h-[1]benzothiolo[2,3-d]pyrimidine-4-thione Chemical compound N1=CNC(=S)C2=C1SC1=C2CCC(C)C1 RBWNDBNSJFCLBZ-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- HCXXPQQXBPCCEM-JVKKMSGISA-N C/1=C/CCC=C/CC1.[Ag] Chemical compound C/1=C/CCC=C/CC1.[Ag] HCXXPQQXBPCCEM-JVKKMSGISA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- 229910021608 Silver(I) fluoride Inorganic materials 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- YRXWPCFZBSHSAU-UHFFFAOYSA-N [Ag].[Ag].[Te] Chemical compound [Ag].[Ag].[Te] YRXWPCFZBSHSAU-UHFFFAOYSA-N 0.000 description 1
- 229910052946 acanthite Inorganic materials 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229940049676 bismuth hydroxide Drugs 0.000 description 1
- TZSXPYWRDWEXHG-UHFFFAOYSA-K bismuth;trihydroxide Chemical compound [OH-].[OH-].[OH-].[Bi+3] TZSXPYWRDWEXHG-UHFFFAOYSA-K 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- IQBJFLXHQFMQRP-UHFFFAOYSA-K calcium;zinc;phosphate Chemical compound [Ca+2].[Zn+2].[O-]P([O-])([O-])=O IQBJFLXHQFMQRP-UHFFFAOYSA-K 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000004697 chelate complex Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- OJKANDGLELGDHV-UHFFFAOYSA-N disilver;dioxido(dioxo)chromium Chemical compound [Ag+].[Ag+].[O-][Cr]([O-])(=O)=O OJKANDGLELGDHV-UHFFFAOYSA-N 0.000 description 1
- WGAKFMRZYUGMGU-UHFFFAOYSA-L disilver;selenate Chemical compound [Ag+].[Ag+].[O-][Se]([O-])(=O)=O WGAKFMRZYUGMGU-UHFFFAOYSA-L 0.000 description 1
- KDSXXMBJKHQCAA-UHFFFAOYSA-N disilver;selenium(2-) Chemical compound [Se-2].[Ag+].[Ag+] KDSXXMBJKHQCAA-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- BABIQFTUTNDWMB-UHFFFAOYSA-M fluorosilver;hydrofluoride Chemical compound F.[Ag]F BABIQFTUTNDWMB-UHFFFAOYSA-M 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960001545 hydrotalcite Drugs 0.000 description 1
- 229910001701 hydrotalcite Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- HKSGQTYSSZOJOA-UHFFFAOYSA-N potassium argentocyanide Chemical compound [K+].[Ag+].N#[C-].N#[C-] HKSGQTYSSZOJOA-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- GMUQQCCNKDSQOY-UHFFFAOYSA-M silver 3-oxooxolane-2-carboxylate Chemical compound [Ag+].[O-]C(=O)C1OCCC1=O GMUQQCCNKDSQOY-UHFFFAOYSA-M 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- IMGNYAPMSDUASV-UHFFFAOYSA-K silver arsenate Chemical compound [Ag+].[Ag+].[Ag+].[O-][As]([O-])([O-])=O IMGNYAPMSDUASV-UHFFFAOYSA-K 0.000 description 1
- QBFXQJXHEPIJKW-UHFFFAOYSA-N silver azide Chemical compound [Ag+].[N-]=[N+]=[N-] QBFXQJXHEPIJKW-UHFFFAOYSA-N 0.000 description 1
- XQLMNMQWVCXIKR-UHFFFAOYSA-M silver bromate Chemical compound [Ag+].[O-]Br(=O)=O XQLMNMQWVCXIKR-UHFFFAOYSA-M 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 229940071575 silver citrate Drugs 0.000 description 1
- LFAGQMCIGQNPJG-UHFFFAOYSA-N silver cyanide Chemical compound [Ag+].N#[C-] LFAGQMCIGQNPJG-UHFFFAOYSA-N 0.000 description 1
- 229940098221 silver cyanide Drugs 0.000 description 1
- YSVXTGDPTJIEIX-UHFFFAOYSA-M silver iodate Chemical compound [Ag+].[O-]I(=O)=O YSVXTGDPTJIEIX-UHFFFAOYSA-M 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- MHLYOTJKDAAHGI-UHFFFAOYSA-N silver molybdate Chemical compound [Ag+].[Ag+].[O-][Mo]([O-])(=O)=O MHLYOTJKDAAHGI-UHFFFAOYSA-N 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- KKKDGYXNGYJJRX-UHFFFAOYSA-M silver nitrite Chemical compound [Ag+].[O-]N=O KKKDGYXNGYJJRX-UHFFFAOYSA-M 0.000 description 1
- XNGYKPINNDWGGF-UHFFFAOYSA-L silver oxalate Chemical compound [Ag+].[Ag+].[O-]C(=O)C([O-])=O XNGYKPINNDWGGF-UHFFFAOYSA-L 0.000 description 1
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 1
- 229910000161 silver phosphate Inorganic materials 0.000 description 1
- 229940019931 silver phosphate Drugs 0.000 description 1
- WQIJNCUKAOHNPM-UHFFFAOYSA-L silver selenite Chemical compound [Ag+].[Ag+].[O-][Se]([O-])=O WQIJNCUKAOHNPM-UHFFFAOYSA-L 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- 229940056910 silver sulfide Drugs 0.000 description 1
- XUARKZBEFFVFRG-UHFFFAOYSA-N silver sulfide Chemical compound [S-2].[Ag+].[Ag+] XUARKZBEFFVFRG-UHFFFAOYSA-N 0.000 description 1
- WYCFMBAHFPUBDS-UHFFFAOYSA-L silver sulfite Chemical compound [Ag+].[Ag+].[O-]S([O-])=O WYCFMBAHFPUBDS-UHFFFAOYSA-L 0.000 description 1
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- YPDPYLJJBBKICP-JIZZDEOASA-M silver;(2r)-2-amino-3-hydroxy-3-oxopropane-1-thiolate;nitric acid Chemical compound [Ag+].O[N+]([O-])=O.[S-]C[C@H](N)C(O)=O YPDPYLJJBBKICP-JIZZDEOASA-M 0.000 description 1
- CHACQUSVOVNARW-LNKPDPKZSA-M silver;(z)-4-oxopent-2-en-2-olate Chemical compound [Ag+].C\C([O-])=C\C(C)=O CHACQUSVOVNARW-LNKPDPKZSA-M 0.000 description 1
- KZJPVUDYAMEDRM-UHFFFAOYSA-M silver;2,2,2-trifluoroacetate Chemical compound [Ag+].[O-]C(=O)C(F)(F)F KZJPVUDYAMEDRM-UHFFFAOYSA-M 0.000 description 1
- KBHCPEPZBVLREH-UHFFFAOYSA-M silver;2,4,6-trinitrophenolate;hydrate Chemical compound O.[Ag+].[O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O KBHCPEPZBVLREH-UHFFFAOYSA-M 0.000 description 1
- LMEWRZSPCQHBOB-UHFFFAOYSA-M silver;2-hydroxypropanoate Chemical compound [Ag+].CC(O)C([O-])=O LMEWRZSPCQHBOB-UHFFFAOYSA-M 0.000 description 1
- LTMVKFCRGKWTPA-UHFFFAOYSA-M silver;2-oxopyrrolidine-1-carboxylate Chemical compound [Ag+].[O-]C(=O)N1CCCC1=O LTMVKFCRGKWTPA-UHFFFAOYSA-M 0.000 description 1
- CLDWGXZGFUNWKB-UHFFFAOYSA-M silver;benzoate Chemical compound [Ag+].[O-]C(=O)C1=CC=CC=C1 CLDWGXZGFUNWKB-UHFFFAOYSA-M 0.000 description 1
- SLERPCVQDVNSAK-UHFFFAOYSA-N silver;ethyne Chemical compound [Ag+].[C-]#C SLERPCVQDVNSAK-UHFFFAOYSA-N 0.000 description 1
- DOQQTKLDEQSKIE-UHFFFAOYSA-N silver;isocyanate Chemical compound [Ag+].[N-]=C=O DOQQTKLDEQSKIE-UHFFFAOYSA-N 0.000 description 1
- NSVHDIYWJVLAGH-UHFFFAOYSA-M silver;n,n-diethylcarbamodithioate Chemical compound [Ag+].CCN(CC)C([S-])=S NSVHDIYWJVLAGH-UHFFFAOYSA-M 0.000 description 1
- RAVDHKVWJUPFPT-UHFFFAOYSA-N silver;oxido(dioxo)vanadium Chemical compound [Ag+].[O-][V](=O)=O RAVDHKVWJUPFPT-UHFFFAOYSA-N 0.000 description 1
- CYLMOXYXYHNGHZ-UHFFFAOYSA-M silver;propanoate Chemical compound [Ag+].CCC([O-])=O CYLMOXYXYHNGHZ-UHFFFAOYSA-M 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- JUWGUJSXVOBPHP-UHFFFAOYSA-B titanium(4+);tetraphosphate Chemical compound [Ti+4].[Ti+4].[Ti+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O JUWGUJSXVOBPHP-UHFFFAOYSA-B 0.000 description 1
- QUTYHQJYVDNJJA-UHFFFAOYSA-K trisilver;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ag+].[Ag+].[Ag+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QUTYHQJYVDNJJA-UHFFFAOYSA-K 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本件発明は、使用者の手や指に付着した細菌、カビやウイルス等を死滅させるための粘稠な抗菌剤に関する。 The present invention relates to a viscous antibacterial agent for killing bacteria, molds, viruses, and the like attached to a user's hand or finger.
従来、使用者の手や指に付着した細菌、カビやウイルス等を死滅させるために、有効成分としてエタノールを配合した粘稠な抗菌剤が知られている。 BACKGROUND ART Viscous antibacterial agents containing ethanol as an active ingredient in order to kill bacteria, molds, viruses, and the like attached to the hands and fingers of users have been known.
例えば、特許文献1には、塩化ベンザルコニウム、局方エタノール、カルボキシビニルポリマー、ヒドロキシプロピルメチルセルロースなどを含有し粘度が20,000センチポイズである消毒剤が開示されている。 For example, Patent Document 1 discloses a disinfectant having a viscosity of 20,000 centipoise, which contains benzalkonium chloride, local ethanol, carboxyvinyl polymer, hydroxypropylmethylcellulose, and the like.
しかしながら、特許文献1の消毒剤では、使用直後においてはエタノールが十分含有されているために、菌の増殖を抑制する抗菌効果を有するが、使用者の体温や外気温などによって徐々にエタノールが揮発していき、徐々にその抗菌効果が逓減するという課題があった。そして、塩化ベンザルコニウムも抗菌効果を有するところ、エタノールよりも抗菌効果が持続するものの、数時間しか効力が持続しないために、やはり徐々にその抗菌効果が逓減するという課題があった。また、使用者が繰り返し手や指に塗り重ねることで、抗菌成分である塩化ベンザルコニウムが濃縮され、掻痒を伴った皮疹、発赤を伴う小水疱などを示すことも懸念される。 However, the disinfectant of Patent Literature 1 has an antibacterial effect of suppressing bacterial growth because ethanol is sufficiently contained immediately after use, but the ethanol gradually evaporates due to the user's body temperature or external temperature. Then, there was a problem that its antibacterial effect gradually decreased. In addition, benzalkonium chloride also has an antibacterial effect. However, although the antibacterial effect lasts longer than ethanol, the effect lasts for only a few hours, so that the antibacterial effect gradually decreases gradually. In addition, there is a concern that if the user repeatedly coats the hands and fingers, the antibacterial component benzalkonium chloride will be concentrated, and it will cause skin rash accompanied by pruritus, vesicles accompanied by redness, and the like.
そこで、本件発明では、エタノールを含有する粘稠な抗菌剤について、使用者の手や指などに付着させた直後から数時間だけでなく、さらに時間が経過した後であっても皮膚刺激性が低く高い抗菌効果を奏する抗菌剤を提供することを目的とする。 Therefore, in the present invention, the viscous antibacterial agent containing ethanol has a skin irritancy not only several hours immediately after being attached to the user's hand or finger, but also after a further time has passed. An object of the present invention is to provide an antibacterial agent having a low and high antibacterial effect.
〔1〕すなわち、銀担持体と、エタノールと、増粘化合物を、含有する粘稠抗菌剤であって、25℃における粘度が0.05〜100Pa・sであることを特徴とする粘稠抗菌剤である。 [1] That is, a viscous antibacterial agent containing a silver carrier, ethanol, and a thickening compound, wherein the viscosity at 25 ° C. is 0.05 to 100 Pa · s. Agent.
〔2〕そして、前記銀担持体が0.01〜2.0重量%、前記エタノールが30〜75重量%、前記増粘化合物が0.15〜2.0重量%含有されていることを特徴とする前記〔1〕に記載の粘稠抗菌剤である。 [2] And, the silver carrier is 0.01 to 2.0% by weight, the ethanol is 30 to 75% by weight, and the thickening compound is 0.15 to 2.0% by weight. The viscous antibacterial agent according to the above [1].
〔3〕そして、前記増粘化合物が、アクリル酸系化合物又は多糖類であることを特徴とする前記〔1〕又は前記〔2〕に記載の粘稠抗菌剤である。 [3] The viscous antibacterial agent according to [1] or [2], wherein the thickening compound is an acrylic acid compound or a polysaccharide.
〔4〕そして、前記増粘化合物が、カルボキシビニルポリマーであることを特徴とする前記〔1〕から前記〔3〕のいずれかに記載の粘稠抗菌剤である。 [4] The viscous antibacterial agent according to any one of [1] to [3], wherein the thickening compound is a carboxyvinyl polymer.
〔5〕そして、前記銀担持体が、金属銀を表面に担持したリン酸カルシウムであることを特徴とする前記〔1〕から前記〔4〕のいずれかに記載の粘稠抗菌剤である。 [5] The viscous antibacterial agent according to any of [1] to [4], wherein the silver carrier is calcium phosphate having metallic silver supported on the surface.
本件発明によれば、エタノールを含有する粘稠な抗菌剤について、使用者の手や指などに付着させた直後だけでなく、エタノールが揮発する程度の時間が経過した後であっても高い抗菌効果を奏することができる。これにより、緑膿菌や黄色ブドウ球菌、大腸菌など、手指を介して感染するとされる様々な病原性細菌を抑制することで感染症や食中毒を予防する効果も奏する。 According to the present invention, the viscous antibacterial agent containing ethanol has a high antibacterial property not only immediately after being attached to a user's hand or finger, but also after the time for which the ethanol evaporates. The effect can be achieved. This also has the effect of preventing infectious diseases and food poisoning by suppressing various pathogenic bacteria, such as Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli, which are supposed to be transmitted through fingers.
以下、本件発明の粘稠抗菌剤に関する実施形態について詳しく説明する。なお、説明中における範囲を示す表記のある場合は、上限と下限を含有するものである。 Hereinafter, embodiments of the viscous antibacterial agent of the present invention will be described in detail. In addition, when there is a notation indicating the range in the description, it includes the upper limit and the lower limit.
本件発明における銀担持体は、金属銀、銀イオン、銀塩など銀の原子を担持している化合物であり、溶出した銀イオンが、細菌、カビやウイルスの細胞内に入り込み酵素の働きを阻害や不活化するなどして抗菌効果を奏する有効成分である。 The silver carrier in the present invention is a compound that supports silver atoms such as metallic silver, silver ions, and silver salts, and the eluted silver ions enter the cells of bacteria, molds and viruses and inhibit the function of enzymes. It is an active ingredient that exerts an antibacterial effect by inactivating or inactivating it.
銀塩としては、例えば、酢酸銀、アセチルアセトン酸銀、アジ化銀、銀アセチリド、ヒ酸銀、安息香酸銀、フッ化水素銀、臭素酸銀、臭化銀、炭酸銀、塩化銀、塩素酸銀、クロム酸銀、クエン酸銀、シアン酸銀、シアン化銀、(cis,cis−1,5−シクロオクタジエン)−1,1,1,5,5,5−ヘキサフルオロアセチルアセトン酸銀、ジエチルジチオカルバミン酸銀、フッ化銀(I)、フッ化銀(II)、7,7−ジメチル−1,1,1,2,2,3,3−ヘプタフルオロ−4,6−オクタンジオン酸銀、ヘキサフルオロアンチモン酸銀、ヘキサフルオロヒ酸銀、ヘキサフルオロリン酸銀、ヨウ素酸銀、ヨウ化銀、イソチオシアン酸銀、シアン化銀カリウム、乳酸銀、モリブデン酸銀、硝酸銀、亜硝酸銀、酸化銀(I)、酸化銀(II)、シュウ酸銀、過塩素酸銀、ペルフルオロ酪酸銀、ペルフルオロプロピオン酸銀、過マンガン酸銀、過レニウム酸銀、リン酸銀、ピクリン酸銀一水和物、プロピオン酸銀、セレン酸銀、セレン化銀、亜セレン酸銀、スルファジアジン銀、硫酸銀、硫化銀、亜硫酸銀、テルル化銀、テトラフルオロ硼酸銀、テトラヨードムキュリウム酸銀、テトラタングステン酸銀、チオシアン酸銀、p−トルエンスルホン酸銀、トリフルオロメタンスルホン酸銀、トリフルオロ酢酸銀、バナジン酸銀等や、ヒスチジン銀錯体、メチオニン銀錯体、システイン銀錯体、アスパラギン酸銀錯体、ピロリドンカルボン酸銀錯体、オキソテトラヒドロフランカルボン酸銀錯体、イミダゾール銀錯体などが好ましい。 Examples of the silver salt include silver acetate, silver acetylacetonate, silver azide, silver acetylide, silver arsenate, silver benzoate, silver hydrogen fluoride, silver bromate, silver bromide, silver carbonate, silver chloride, and chloric acid. Silver, silver chromate, silver citrate, silver cyanate, silver cyanide, silver (cis, cis-1,5-cyclooctadiene) -1,1,1,5,5,5-hexafluoroacetylacetonate; Silver diethyldithiocarbamate, silver (I) fluoride, silver (II) fluoride, silver 7,7-dimethyl-1,1,1,2,2,3,3-heptafluoro-4,6-octanedionate , Silver hexafluoroantimonate, silver hexafluoroarsenate, silver hexafluorophosphate, silver iodate, silver iodide, silver isothiocyanate, potassium silver cyanide, silver lactate, silver molybdate, silver nitrate, silver nitrite, silver oxide (I), silver oxide ( I), silver oxalate, silver perchlorate, silver perfluorobutyrate, silver perfluoropropionate, silver permanganate, silver perrhenate, silver phosphate, silver picrate monohydrate, silver propionate, silver selenate , Silver selenide, silver selenite, silver sulfadiazine, silver sulfate, silver sulfide, silver sulfite, silver telluride, silver tetrafluoroborate, silver tetraiodomuccurate, silver tetratungstate, silver thiocyanate, p-toluene Silver sulfonate, silver trifluoromethanesulfonate, silver trifluoroacetate, silver vanadate, etc., silver histidine complex, silver methionine complex, silver cysteine complex, silver aspartate complex, silver pyrrolidonecarboxylate complex, silver oxotetrahydrofurancarboxylate complex And an imidazole silver complex.
銀を担持している担体としては、リン酸亜鉛カルシウム、リン酸カルシウム、リン酸ジルコニウム、リン酸アルミニウム、ケイ酸カルシウム、活性炭、活性アルミナ、シリカゲル、ゼオライト、ヒドロキシアパタイト、リン酸ジルコニウム、リン酸チタン、チタン酸カリウム、含水酸化ビスマス、含水酸化ジルコニウム、ハイドロタルサイトなどの無機化合物や銀イオンとキレート錯体を形成可能なアミノ酸などの有機化合物が好ましい。 Examples of the carrier supporting silver include zinc calcium phosphate, calcium phosphate, zirconium phosphate, aluminum phosphate, calcium silicate, activated carbon, activated alumina, silica gel, zeolite, hydroxyapatite, zirconium phosphate, titanium phosphate, and titanium. Inorganic compounds such as potassium acid, bismuth hydroxide, zirconium hydroxide and hydrotalcite, and organic compounds such as amino acids capable of forming a chelate complex with silver ions are preferred.
本件発明の粘稠抗菌剤における銀担持体の配合割合としては、0.01〜2.0重量%が好ましく、0.05〜1.5重量%がより好ましい。銀担持体の配合割合が、この範囲にあると、使用者の手や指などに塗布したのちにエタノールが揮発するくらいの時間が経過しても銀担持体に含まれる銀は使用者の体温や外気温によって揮発することがないために、抗菌効果を持続させることができ、また、銀担持体が凝集して沈殿することなく粘稠抗菌剤中に均一に分散するために、いつ使用しても安定した抗菌効果を奏することができる。また、銀担持体は、皮膚刺激性がほとんどないため、使用者が本件発明の粘稠抗菌剤を繰り返し手や指に塗り重ねたとしても炎症などを示すおそれがほとんどない。 The mixing ratio of the silver carrier in the viscous antibacterial agent of the present invention is preferably 0.01 to 2.0% by weight, and more preferably 0.05 to 1.5% by weight. When the compounding ratio of the silver carrier is within this range, the silver contained in the silver carrier remains at the body temperature of the user even after the time that the ethanol evaporates after the application to the user's hand or finger. The antibacterial effect can be sustained because it does not volatilize due to heat or outside temperature, and it is used when the silver carrier is uniformly dispersed in the viscous antibacterial agent without aggregation and precipitation. However, a stable antibacterial effect can be achieved. Further, since the silver carrier has little skin irritation, there is almost no risk of irritation or the like even if the user repeatedly applies the viscous antibacterial agent of the present invention to hands or fingers.
本件発明におけるエタノールは、菌の生育を阻み、また、菌を死滅させる抗菌効果を奏する有効成分である。 Ethanol in the present invention is an active ingredient that has an antibacterial effect that inhibits the growth of bacteria and kills the bacteria.
本件発明の粘稠抗菌剤におけるエタノールの含有割合は、30〜75重量%が好ましく、55〜65重量%がさらに好ましい。エタノールの含有割合がこの範囲にあると、菌などの増殖の抑制及び死滅などの抗菌効果を有するとともに、増粘化合物を均一に分散することができる。 The content of ethanol in the viscous antibacterial agent of the present invention is preferably 30 to 75% by weight, more preferably 55 to 65% by weight. When the content ratio of ethanol is in this range, it has an antibacterial effect such as suppression of growth and death of bacteria and the like, and can uniformly disperse the thickening compound.
本件発明における増粘化合物は、抗菌剤の粘性を向上させるための化合物である。具体的には、アクリル酸系化合物や多糖類が用いられることが好ましい。アクリル酸系化合物としては、カルボキシビニルポリマー、ポリアクリル酸ナトリウムなどが好ましい。多糖類としては、ヒドロキシエチル基が導入されたセルロース誘導体であるヒドロキシエチルセルロース、ヒドロキシプロピル基が導入されたセルロース誘導体であるヒドロキシプロピルセルロース、ヒドロキシプロピル基及び低級アルキル基のうちメチル基が導入されたセルロース誘導体であるヒドロキシプロピルメチルセルロース、ヒドロキシプロピルメチルセルロースにステアリルグリシジルエーテルなどの疎水性のアルキル基を有するグリシジルエーテルを反応させて得られる疎水化ヒドロキシプロピルメチルセルロース、ヒドロキシエチル基及びヒドロキシプロピル基が導入されたセルロースであるヒドロキシエチルヒドロキシプロピルセルロース、カルボキシメチル基が導入されたセルロースの塩であるカルボキシメチルセルロースナトリウム、キサンタンガム、アルギン酸ナトリウムなどが好ましい。また、疎水化ヒドロキシプロピルメチルセルロースにおいては、疎水基がステアリル基だけでなく炭素数6〜22などの中鎖及び長鎖アルキル基を用いることもできる。なお、導入されるヒドロキシエチル基及びヒドロキシプロピル基は、セルロース中の水酸基1つに対して1または複数付加することができ、1〜10付加されていることが好ましい。特に、カルボキシビニルポリマーを用いることにより、銀担持体を均一に分散させることができるだけでなく、長期間保存したときにも抗菌剤が黒く変色することを抑制することができる点において好適である。 The thickening compound in the present invention is a compound for improving the viscosity of the antibacterial agent. Specifically, it is preferable to use an acrylic acid compound or a polysaccharide. As the acrylic acid compound, a carboxyvinyl polymer, sodium polyacrylate and the like are preferable. Polysaccharides include hydroxyethyl cellulose which is a cellulose derivative having a hydroxyethyl group introduced, hydroxypropyl cellulose which is a cellulose derivative having a hydroxypropyl group introduced, and cellulose having a methyl group introduced among hydroxypropyl and lower alkyl groups. Hydroxypropyl methylcellulose which is a derivative, hydrophobized hydroxypropylmethylcellulose obtained by reacting glycidyl ether having a hydrophobic alkyl group such as stearyl glycidyl ether with hydroxypropylmethylcellulose, cellulose in which hydroxyethyl group and hydroxypropyl group are introduced. Certain hydroxyethyl hydroxypropyl cellulose, carboxymethyl cellulose which is a salt of cellulose having a carboxymethyl group introduced Scan sodium, xanthan gum, and sodium alginate are preferable. In the hydrophobized hydroxypropylmethylcellulose, not only a stearyl group but also a medium-chain or long-chain alkyl group having 6 to 22 carbon atoms can be used. One or more hydroxyethyl groups and hydroxypropyl groups can be added to one hydroxyl group in cellulose, and preferably 1 to 10 are added. In particular, the use of a carboxyvinyl polymer is preferable in that not only can the silver carrier be uniformly dispersed, but also the antibacterial agent can be prevented from discoloring black when stored for a long period of time.
本件発明の粘稠抗菌剤における増粘化合物の含有割合は、0.15〜2.0重量%が好ましく、0.2〜1.5重量%がさらに好ましい。増粘化合物の含有割合がこの範囲にあると、抗菌剤中に銀担持体を均一に分散することができ、また、抗菌剤を使用者が手や指などに付着させてもただちに流れ落ちることなく、また、塗り広げるときにものばしやすいとともに、べたつきを感じさせないという効果を奏する。 The content ratio of the thickening compound in the viscous antibacterial agent of the present invention is preferably 0.15 to 2.0% by weight, more preferably 0.2 to 1.5% by weight. When the content of the thickening compound is within this range, the silver carrier can be uniformly dispersed in the antibacterial agent, and the antibacterial agent does not immediately flow off even if the user attaches it to the hand or finger. In addition, it has the effect of making it easy to spread when spreading, and not giving any stickiness.
増粘化合物を配合することにより抗菌剤の粘度は向上するところ、各種成分を配合して攪拌し均一な白色な溶液となった状態におけるその抗菌剤の粘度はJIS K7117−1に記載のブルックフィールド形回転粘度計B形(東機産業株式会社製、商品名「TVB−10M」)を用いた計測において、25℃条件下0.05〜100Pa・sであることが好ましく、50〜5000mPa・sであることがさらに好ましく、100〜3000mPa・sであることがもっとも好ましい。粘度がこの範囲にあると、抗菌液を手などの肌に付着してもただちに流れ落ちることなく、また、塗り広げるときにものばしやすい。 Although the viscosity of the antibacterial agent is improved by compounding the thickening compound, the viscosity of the antibacterial agent in the state of mixing and stirring various components to form a uniform white solution is determined by Brookfield described in JIS K7117-1. In a measurement using a rotary viscometer type B (manufactured by Toki Sangyo Co., Ltd., trade name “TVB-10M”), the pressure is preferably 0.05 to 100 Pa · s at 25 ° C., and 50 to 5000 mPa · s. Is more preferable, and most preferably 100 to 3000 mPa · s. When the viscosity is in this range, even if the antibacterial liquid adheres to the skin such as hands, the antibacterial liquid does not run off immediately and is easy to spread when spread.
本件発明の粘稠抗菌剤において、水を配合することもできる。配合する水としては、日本薬局方規格の水が好ましく、例えば、水道水、井戸水などである常水、そして、蒸留、イオン交換膜によるイオン交換処理、限外ろ過膜による限外ろ過処理のいずれか、またはそれらの組み合わせにより常水を処理した精製水、そして、加熱等により精製水を滅菌処理した滅菌精製水などが好ましい。水の含有割合は、20〜50重量%であることが好ましい。 In the viscous antibacterial agent of the present invention, water can be blended. The water to be blended is preferably water of the Japanese Pharmacopoeia standard, for example, tap water, ordinary water such as well water, and any of distillation, ion exchange treatment with an ion exchange membrane, and ultrafiltration treatment with an ultrafiltration membrane Alternatively, purified water obtained by treating ordinary water with a combination thereof, and sterilized purified water obtained by sterilizing purified water by heating or the like are preferable. The water content is preferably 20 to 50% by weight.
本件発明の粘稠抗菌剤のpHが、25℃において2〜7であることが好ましく、3〜6であることがさらに好ましい。本件発明の粘稠抗菌剤のpHが上記範囲にあると、エタノールや銀担持体の有効成分だけでなく、液性によっても酸性領域に耐性がない多くの菌に対して、抗菌効果を奏することができる。また、増粘化合物として、カルボキシビニルポリマー、ポリアクリル酸ナトリウムなどのアクリル酸系化合物を用いた場合には、分子鎖が広がり増粘することが可能となる。本件発明の粘稠抗菌剤のpHを調整するために、クエン酸、グルコン酸、コハク酸、炭酸カリウム、炭酸水素ナトリウム、トリエタノールアミンなどのpH調整剤を添加することができる。 The pH of the viscous antibacterial agent of the present invention is preferably 2 to 7 at 25 ° C, more preferably 3 to 6. When the pH of the viscous antibacterial agent of the present invention is within the above range, the viscous antibacterial agent exhibits an antibacterial effect not only on the active ingredients of ethanol and the silver carrier, but also on many bacteria that are not resistant to the acidic region even by liquidity. Can be. When an acrylic acid compound such as a carboxyvinyl polymer or sodium polyacrylate is used as the thickening compound, the molecular chain can be expanded and the viscosity can be increased. In order to adjust the pH of the viscous antibacterial agent of the present invention, a pH adjuster such as citric acid, gluconic acid, succinic acid, potassium carbonate, sodium hydrogencarbonate, and triethanolamine can be added.
本件発明の粘稠抗菌剤には、上記した成分の他に、必要に応じて、グリセリン、プロピレングリコール、ブチレングリコール、ソルビットなどの保湿剤である多価アルコール、炭酸塩などの発泡剤、非イオン性・アニオン性・カチオン性などの界面活性剤、BHTなどの抗酸化剤、緩衝剤、香料、色素などを配合することもできる。 In the viscous antibacterial agent of the present invention, in addition to the above-mentioned components, if necessary, glycerin, propylene glycol, butylene glycol, humectants such as polyhydric alcohols such as sorbit, foaming agents such as carbonates, nonionic A surfactant such as anionic, anionic, or cationic, an antioxidant such as BHT, a buffer, a fragrance, a dye, and the like can also be blended.
以下、本件発明の実施例について具体的に説明する。なお、本件発明は以下の実施例に限定されるものではない。また、数値範囲を示す表現は、上限及び下限を含有する。 Hereinafter, embodiments of the present invention will be specifically described. The present invention is not limited to the following embodiments. Further, expressions indicating numerical ranges include upper and lower limits.
<実施例1>
容量が200mlのグリフィンビーカーに、エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてカルボキシビニルポリマーを0.6g、精製水を38.6g加え、pH調整剤としてトリエタノールアミンを少量滴下し、均一な白色の溶液になるまで攪拌し、合計100gの抗菌剤を得た。
<Example 1>
To a Griffin beaker having a capacity of 200 ml, 60.7 g of ethanol, 0.1 g of calcium phosphate supporting metallic silver as a silver carrier, 0.6 g of a carboxyvinyl polymer as a thickening compound, and 38.6 g of purified water were added, and a pH adjuster was added. , A small amount of triethanolamine was added dropwise, and the mixture was stirred until a uniform white solution was obtained, thereby obtaining a total of 100 g of an antibacterial agent.
<実施例2>
エタノールを60.4g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてヒドロキシエチルセルロースを1.1g、精製水を38.4g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 2>
Example 1 was repeated except that 60.4 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 1.1 g of hydroxyethyl cellulose as a thickening compound, 38.4 g of purified water, and an appropriate amount of a pH adjuster were added. A total of 100 g of the antibacterial agent was obtained in the same manner as in the above.
<実施例3>
エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてヒドロキシプロピルセルロースを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 3>
Example 1 except that 60.7 g of ethanol, 0.1 g of calcium phosphate carrying metal silver as a silver carrier, 0.6 g of hydroxypropyl cellulose as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster were added. As in Example 1, a total of 100 g of the antibacterial agent was obtained.
<実施例4>
エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてヒドロキシプロピルメチルセルロースを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 4>
Example 1 except that 60.7 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.6 g of hydroxypropylmethylcellulose as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster were added. As in Example 1, a total of 100 g of the antibacterial agent was obtained.
<実施例5>
エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物として疎水化ヒドロキシプロピルメチルセルロースを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 5>
Except for adding 60.7 g of ethanol, 0.1 g of calcium phosphate carrying metal silver as a silver carrier, 0.6 g of hydrophobized hydroxypropylmethylcellulose as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster, As in Example 1, a total of 100 g of the antibacterial agent was obtained.
<実施例6>
エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてポリアクリル酸ナトリウムを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 6>
Except that 60.7 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.6 g of sodium polyacrylate as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster were added. As in Example 1, a total of 100 g of the antibacterial agent was obtained.
<実施例7>
エタノールを60.9g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてアルギン酸ナトリウムを0.2g、精製水を38.8g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 7>
Example 1 except that 60.9 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.2 g of sodium alginate as a thickening compound, 38.8 g of purified water, and an appropriate amount of a pH adjuster were added. A total of 100 g of the antibacterial agent was obtained in the same manner as in the above.
<実施例8>
エタノールを60.9g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてカルボキシメチルセルロースナトリウムを0.2g、精製水を38.8g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 8>
Example 1 except that 60.9 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.2 g of sodium carboxymethylcellulose as a thickening compound, 38.8 g of purified water, and an appropriate amount of a pH adjuster were added. As in Example 1, a total of 100 g of the antibacterial agent was obtained.
<実施例9>
エタノールを60.9g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてキサンタンガムを0.2g、精製水を38.8g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 9>
Example 1 was the same as Example 1 except that 60.9 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.2 g of xanthan gum as a thickening compound, 38.8 g of purified water, and an appropriate amount of a pH adjuster were added. Similarly, a total of 100 g of the antibacterial agent was obtained.
<比較例1>
エタノールを60.8g、増粘化合物としてカルボキシビニルポリマーを0.6g、精製水を38.7g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Comparative Example 1>
A total of 100 g of an antibacterial agent was obtained in the same manner as in Example 1, except that 60.8 g of ethanol, 0.6 g of carboxyvinyl polymer as a thickening compound, 38.7 g of purified water, and an appropriate amount of a pH adjuster were added.
<比較例2>
エタノールを61.0g、銀担持体として金属銀担持リン酸カルシウムを0.1g、精製水を38.8g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Comparative Example 2>
A total of 100 g of an antibacterial agent was obtained in the same manner as in Example 1, except that 61.0 g of ethanol, 0.1 g of calcium phosphate carrying metal silver as a silver carrier, 38.8 g of purified water, and an appropriate amount of a pH adjuster were added. .
<比較例3>
エタノールを60.7g、塩化ベンザルコニウムを0.1g、増粘化合物としてカルボキシビニルポリマーを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Comparative Example 3>
Same as Example 1 except that 60.7 g of ethanol, 0.1 g of benzalkonium chloride, 0.6 g of carboxyvinyl polymer as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster were added. A total of 100 g of the antibacterial agent was obtained.
上記の抗菌剤の評価方法については、以下の方法で確認した。 The evaluation method of the above antibacterial agent was confirmed by the following method.
〔外観〕
外観について、配合した抗菌剤を24時間静置し目視にて確認した。黒っぽい変色や沈殿物が無いものを○と評価し、変色や沈殿物がわずかに生じているときは△と評価し、変色、沈殿物が大きく生じているときは×と評価した。これらのうち、○及び△を良好、×を不良と判断した。
〔appearance〕
About the appearance, the compounded antibacterial agent was allowed to stand for 24 hours and visually checked. Those with no dark discoloration or sediment were evaluated as ○, when discoloration or sediment was slightly generated, evaluated as Δ, and when discoloration or sediment was largely generated, evaluated as x. Among these, ○ and Δ were judged as good, and × was judged as bad.
〔pH〕
pHについて、pH7(中性リン酸塩)標準液(pH 6.86 at 25℃)をゼロ点とし、pH4(フタル酸塩)標準液(pH 4.01 at 25℃)またはpH9(ホウ酸塩)標準液(pH 9.18 at 25℃)で校正したpH測定器(株式会社堀場製作所製、商品名F-52)を用いて、25℃に補正した値として測定した。
[PH]
With respect to pH, a pH 7 (neutral phosphate) standard solution (pH 6.86 at 25 ° C.) was set to zero, and a pH 4 (phthalate) standard solution (pH 4.01 at 25 ° C.) or pH 9 (borate) was used. ) Using a pH measuring device (F-52, manufactured by Horiba, Ltd.) calibrated with a standard solution (pH 9.18 at 25 ° C.), the value was measured as a value corrected to 25 ° C.
〔粘度〕
上記の抗菌剤を容器に入れて25℃の恒温槽にて静置して、上記の抗菌剤が25℃になってからJIS K7117−1に記載のブルックフィールド形回転粘度計B形(東機産業株式会社製、商品名「TVB−10M」)にローター(No.20)を取り付けて計測した。
〔viscosity〕
The above-mentioned antibacterial agent was put in a container and allowed to stand in a constant temperature bath at 25 ° C., and after the above-mentioned antibacterial agent reached 25 ° C., a Brookfield-type rotational viscometer B type described in JIS K7117-1 (Toki Machine Co., Ltd.) The measurement was performed by attaching a rotor (No. 20) to a trade name “TVB-10M” manufactured by Sangyo Co., Ltd.).
〔使用感〕
使用感について、配合した抗菌剤を掌に滴下して塗り広げたときの官能により評価した。掌からこぼれ落ちにくく、糊状の剥離物であるヨレが生じたり、べたついたりすることのないものを○と評価し、多少掌からこぼれ落ち、ヨレやべたつきを感じる物を△と評価し、掌からこぼれ落ちやすく、明らかにヨレやべたつきを感じる物を×と評価した。これらのうち、○及び△を良好、×を不良と判断した。これらの結果を表1に併せて示す。
(Usability)
The feeling of use was evaluated based on the organoleptic effect when the compounded antibacterial agent was dropped on the palm and spread. Those that are hard to spill from the palm and do not produce sticky peels or sticky are evaluated as ○, and those that spill slightly from the palm and feel swelling or sticky are evaluated as △, and spilled from the palm Those which were easy and clearly felt stickiness and stickiness were evaluated as x. Among these, ○ and Δ were judged as good, and × was judged as bad. The results are shown in Table 1.
〔効力の持続性〕
流水にて手洗いを行った後、ハンドスタンプ培地(SCD培地)に掌を押し付け、消毒 前の菌を採取した。次に配合した抗菌剤約2gを手に擦りこみ、乾燥させた後ハンドス タンプ培地に掌を押し付け、塗布直後の菌を採取した。その後、滅菌済みグローブを装 着し3時間後及び6時間後にグローブをはずしてハンドスタンプ培地に掌を押し付け、 菌を採取した。これらのハンドスタンプ培地を約35℃の恒温槽にて約24時間以上培 養し,生菌数(cfu:コロニー形成単位)を測定した。3時間後、6時間後菌数が消毒 前よりも低く、抗菌効果が維持できているものを○と評価し、3時間後、6時間後菌数 が消毒前よりも増加し抗菌効果が維持できていないもの×と評価した。これらのうち、 ○を良好、×を不良と判断した。これらの結果を図1〜4と表1に示す。
(Persistence of efficacy)
After hand washing with running water, the palm was pressed against a hand-stamp medium (SCD medium) to collect the bacteria before disinfection. Next, about 2 g of the compounded antibacterial agent was rubbed in the hand and dried, and then the palm was pressed against a hand stamp medium to collect the bacteria immediately after application. Then, after 3 hours and 6 hours after the sterilized gloves were attached, the gloves were removed and the palm was pressed against the hand-stamp medium to collect the bacteria. The hand-stamped medium was cultured in a thermostat at about 35 ° C. for about 24 hours or more, and the viable cell count (cfu: colony forming unit) was measured. After 3 hours and 6 hours, the number of bacteria was lower than before the disinfection and the antibacterial effect was maintained, and the sample was evaluated as ○. After 3 hours and 6 hours, the number of bacteria increased compared to before the disinfection and the antibacterial effect was maintained. It was evaluated as x which could not be made. Among these, ○ was judged as good and X was judged as bad. These results are shown in FIGS.
これらの実施例1〜9、比較例1〜3の組成及び試験結果を表1にまとめて示す。 Table 1 shows the compositions and test results of Examples 1 to 9 and Comparative Examples 1 to 3.
表1に示すように、実施例1〜9の抗菌剤において、銀担持体を添加しても沈殿や変色することなく均一な白色の液となり、手指に塗り広げたときに掌からこぼれ落ちにくく、糊状の剥離物であるヨレが生じたり、べたついたりすることのない良好な使用感とすることができ、さらに、所定時間経過後であっても抗菌効果を持続することができた。また、所定時間経過後であっても、塗広げた箇所に刺激性を感じることはなかった。 As shown in Table 1, in the antibacterial agents of Examples 1 to 9, even when a silver carrier was added, the solution became a uniform white liquid without precipitation or discoloration, and hardly spilled from the palm when spread on fingers. A good feeling of use without sticking or sticking as a paste-like peeled product was obtained, and the antibacterial effect could be maintained even after a lapse of a predetermined time. Further, even after the elapse of the predetermined time, no irritation was felt in the spread area.
Claims (5)
エタノールと、
増粘化合物を含有する粘稠抗菌剤であって、
25℃における粘度が0.05〜100Pa・sであることを特徴とする粘稠抗菌剤。 A silver carrier;
Ethanol and
A viscous antibacterial agent containing a thickening compound,
A viscous antibacterial agent having a viscosity at 25 ° C. of 0.05 to 100 Pa · s.
前記エタノールが30〜75重量%、
前記増粘化合物が0.15〜2.0重量%含有されていることを特徴とする請求項1に記載の粘稠抗菌剤。 0.01 to 2.0% by weight of the silver carrier;
30 to 75% by weight of the ethanol,
The viscous antibacterial agent according to claim 1, wherein the thickening compound is contained in an amount of 0.15 to 2.0% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018146611A JP2020019746A (en) | 2018-08-03 | 2018-08-03 | Viscous antibacterial agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018146611A JP2020019746A (en) | 2018-08-03 | 2018-08-03 | Viscous antibacterial agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2020019746A true JP2020019746A (en) | 2020-02-06 |
Family
ID=69589125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018146611A Pending JP2020019746A (en) | 2018-08-03 | 2018-08-03 | Viscous antibacterial agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2020019746A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021224481A1 (en) * | 2020-05-07 | 2021-11-11 | Giger & Klingler Ag | Hand sanitizer |
JP2022045264A (en) * | 2020-09-08 | 2022-03-18 | 信越化学工業株式会社 | Alcohol composition |
WO2022163694A1 (en) * | 2021-01-29 | 2022-08-04 | 花王株式会社 | Composition for external application |
WO2022249748A1 (en) * | 2021-05-24 | 2022-12-01 | 住友精化株式会社 | Gel composition |
JP7361004B2 (en) | 2020-09-08 | 2023-10-13 | 信越化学工業株式会社 | Method for producing alcohol composition |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03218765A (en) * | 1989-11-14 | 1991-09-26 | Sangi:Kk | Antimicrobial ceramics material |
JPH06199700A (en) * | 1992-12-28 | 1994-07-19 | Toko Yakuhin Kogyo Kk | Quick-drying gel-type disinfectant for finger |
JPH06271472A (en) * | 1992-10-14 | 1994-09-27 | Matsushita Electric Ind Co Ltd | Antiviral composition and its production |
JPH0892078A (en) * | 1994-09-16 | 1996-04-09 | Osaka Seiyaku:Kk | Disinfectant composition |
JP2008143878A (en) * | 2006-12-13 | 2008-06-26 | Kawamoto Sangyo Kk | Disinfectant composition for digiti manus |
JP2010163419A (en) * | 2008-12-16 | 2010-07-29 | Kao Corp | Hand disinfectant composition |
JP2012144481A (en) * | 2011-01-12 | 2012-08-02 | Kao Corp | Finger disinfectant composition |
JP2013515679A (en) * | 2009-12-24 | 2013-05-09 | パーレン コンヴァーティング アクチェンゲゼルシャフト | Antifungal material |
WO2016020168A1 (en) * | 2014-08-06 | 2016-02-11 | Unilever N.V. | A process for preparing an antimicrobial particulate composition |
-
2018
- 2018-08-03 JP JP2018146611A patent/JP2020019746A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03218765A (en) * | 1989-11-14 | 1991-09-26 | Sangi:Kk | Antimicrobial ceramics material |
JPH06271472A (en) * | 1992-10-14 | 1994-09-27 | Matsushita Electric Ind Co Ltd | Antiviral composition and its production |
JPH06199700A (en) * | 1992-12-28 | 1994-07-19 | Toko Yakuhin Kogyo Kk | Quick-drying gel-type disinfectant for finger |
JPH0892078A (en) * | 1994-09-16 | 1996-04-09 | Osaka Seiyaku:Kk | Disinfectant composition |
JP2008143878A (en) * | 2006-12-13 | 2008-06-26 | Kawamoto Sangyo Kk | Disinfectant composition for digiti manus |
JP2010163419A (en) * | 2008-12-16 | 2010-07-29 | Kao Corp | Hand disinfectant composition |
JP2013515679A (en) * | 2009-12-24 | 2013-05-09 | パーレン コンヴァーティング アクチェンゲゼルシャフト | Antifungal material |
JP2012144481A (en) * | 2011-01-12 | 2012-08-02 | Kao Corp | Finger disinfectant composition |
WO2016020168A1 (en) * | 2014-08-06 | 2016-02-11 | Unilever N.V. | A process for preparing an antimicrobial particulate composition |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021224481A1 (en) * | 2020-05-07 | 2021-11-11 | Giger & Klingler Ag | Hand sanitizer |
JP2022045264A (en) * | 2020-09-08 | 2022-03-18 | 信越化学工業株式会社 | Alcohol composition |
JP7361004B2 (en) | 2020-09-08 | 2023-10-13 | 信越化学工業株式会社 | Method for producing alcohol composition |
WO2022163694A1 (en) * | 2021-01-29 | 2022-08-04 | 花王株式会社 | Composition for external application |
WO2022249748A1 (en) * | 2021-05-24 | 2022-12-01 | 住友精化株式会社 | Gel composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020019746A (en) | Viscous antibacterial agent | |
CN109381480B (en) | Compound polyhexamethylene biguanide disinfectant and preparation method thereof | |
CN101646342B (en) | Disinfectant | |
CN106942271B (en) | A kind of compound potassium hydrogen persulfate disinfectant and preparation method thereof | |
KR100437566B1 (en) | Disinfectant composition comprising alcohol, chlorhexidine and an organic acid | |
US5916882A (en) | Povidone iodine (PVP-I) alcohol gel antimicrobial pre-operative skin preparation | |
US8940792B2 (en) | Antimicrobial composition and methods for using same | |
CN102470148B (en) | Silver oxide formulations having improved whiteness characteristics | |
CN108566954A (en) | A kind of disinfectant and its preparation method and application | |
JP2012072134A (en) | Silver ion production liquid for antibacterial use, silver ion antibacterial liquid produced from the liquid, and production method for producing the antibacterial liquid | |
WO1997029742A1 (en) | Lubricating and/or germicidal composition | |
CN108042562A (en) | Disposable disinfectant of the compound alcohol of gel-type and preparation method thereof | |
CN111165478A (en) | Foam type sterilization, disinfection and air purification agent and preparation method and application thereof | |
CN111467283A (en) | Disinfectant gel and preparation method thereof | |
JP7058490B2 (en) | Antibacterial composition that suppresses viruses, bacteria and fungi | |
JPH11349418A (en) | Viscous quick-drying germicidal disinfectant | |
WO2012086760A1 (en) | Disinfectant | |
Estrela et al. | Demetallization of Enterococcus faecalis biofilm: a preliminary study | |
CN102670648B (en) | Liquid iodine disinfectant, preparation method and used container thereof | |
CN111150705A (en) | Alcohol hyaluronic acid disinfectant and preparation method thereof | |
CN111184658A (en) | Hand disinfectant and preparation method thereof | |
JP6869577B2 (en) | Viscous disinfectant | |
JP6866058B2 (en) | Viscous disinfectant | |
JP2011144146A (en) | Gel-like bactericide for finger | |
JP2786634B2 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210531 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220323 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220520 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220720 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221114 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230302 |